- Fulcrum Therapeutics ( NASDAQ: FULC ) on Monday said it had appointed Santiago Arroyo as chief medical officer and Jeff Jacobs as chief scientific officer.
- Arroyo's joining was effective today, while Jacobs will join on Dec. 1, FULC said.
- According to FULC, Arroyo was previously chief medical officer at Momenta Pharmaceuticals which was acquired by Johnson & Johnson ( JNJ ). Arroyo had before that held roles at Bristol-Myers Squibb ( BMY ) and Pfizer ( PFE ).
- Jacobs was most recently chief scientific officer at Goldfinch Bio, and is a 25-year veteran in the fields of drug discovery and target identification, FULC said.
- FULC stock earlier closed -2.9% at $5.61.
For further details see:
Fulcrum Therapeutics names new chief medical officer, chief scientific officer